You have free access to this content

British Journal of Clinical Pharmacology

Cover image for British Journal of Clinical Pharmacology

July 2001

Volume 52, Issue 1

Pages 1–119

  1. Review Series

    1. Top of page
    2. Review Series
    3. Review
    4. Pharmacodynamics
    5. Pharmacokinetics/pharmacodynamics
    6. Drug disposition
    7. Drug interactions
    8. Adverse drug reactions
    9. Drug utilization
    10. Short reports
    11. Book review
    12. Conference Report
    13. Announcement
    1. You have free access to this content
      Learning from previous responses in phase I dose-escalation studies (pages 1–7)

      John Whitehead, Yinghui Zhou, Nigel Stallard, Susan Todd and Anne Whitehead

      Article first published online: 20 DEC 2001 | DOI: 10.1046/j.0306-5251.2001.01383.x

  2. Review

    1. Top of page
    2. Review Series
    3. Review
    4. Pharmacodynamics
    5. Pharmacokinetics/pharmacodynamics
    6. Drug disposition
    7. Drug interactions
    8. Adverse drug reactions
    9. Drug utilization
    10. Short reports
    11. Book review
    12. Conference Report
    13. Announcement
    1. You have free access to this content
  3. Pharmacodynamics

    1. Top of page
    2. Review Series
    3. Review
    4. Pharmacodynamics
    5. Pharmacokinetics/pharmacodynamics
    6. Drug disposition
    7. Drug interactions
    8. Adverse drug reactions
    9. Drug utilization
    10. Short reports
    11. Book review
    12. Conference Report
    13. Announcement
    1. You have free access to this content
  4. Pharmacokinetics/pharmacodynamics

    1. Top of page
    2. Review Series
    3. Review
    4. Pharmacodynamics
    5. Pharmacokinetics/pharmacodynamics
    6. Drug disposition
    7. Drug interactions
    8. Adverse drug reactions
    9. Drug utilization
    10. Short reports
    11. Book review
    12. Conference Report
    13. Announcement
    1. You have free access to this content
    2. You have free access to this content
      Contribution of dihydrocodeine and dihydromorphine to analgesia following dihydrocodeine administration in man: a PK–PD modelling analysis (pages 35–43)

      James A. Webb, Amin Rostami-Hodjegan,, Roslina Abdul-Manap, Ute Hofmann, Gerd Mikus and Farhad Kamali

      Article first published online: 20 DEC 2001 | DOI: 10.1046/j.0306-5251.2001.01414.x

    3. You have free access to this content
      Dihydroergotamine: discrepancy between arterial, arteriolar and pharmacokinetic data (pages 45–51)

      J. N. J. M. De Hoon,, K. A. Poppe, H. H. W. Thijssen, H. A. J. Struijker-Boudier and L. M. A. B. Van Bortel

      Article first published online: 20 DEC 2001 | DOI: 10.1046/j.0306-5251.2001.01415.x

  5. Drug disposition

    1. Top of page
    2. Review Series
    3. Review
    4. Pharmacodynamics
    5. Pharmacokinetics/pharmacodynamics
    6. Drug disposition
    7. Drug interactions
    8. Adverse drug reactions
    9. Drug utilization
    10. Short reports
    11. Book review
    12. Conference Report
    13. Announcement
    1. You have free access to this content
    2. You have free access to this content
      Diurnal variation in the biliary excretion of flomoxef in patients with percutaneous transhepatic biliary drainage (pages 65–68)

      Shuji Hishikawa, Eiji Kobayashi, Koh-ichi Sugimoto, Michio Miyata and Akio Fujimura

      Article first published online: 20 DEC 2001 | DOI: 10.1046/j.0306-5251.2001.01418.x

  6. Drug interactions

    1. Top of page
    2. Review Series
    3. Review
    4. Pharmacodynamics
    5. Pharmacokinetics/pharmacodynamics
    6. Drug disposition
    7. Drug interactions
    8. Adverse drug reactions
    9. Drug utilization
    10. Short reports
    11. Book review
    12. Conference Report
    13. Announcement
    1. You have free access to this content
      Influence of β-adrenoceptor antagonists on the pharmacokinetics of rizatriptan, a 5-HT1B/1D agonist: differential effects of propranolol, nadolol and metoprolol (pages 69–76)

      Michael R. Goldberg, David Sciberras, Marina De Smet, Richard Lowry, Lisa Tomasko, Yih Lee, Timothy V. Olah, Jamie Zhao, Kamlesh P. Vyas, Rita Halpin, Prasad H. Kari and Ian James

      Article first published online: 20 DEC 2001 | DOI: 10.1046/j.0306-5251.2001.01417.x

  7. Adverse drug reactions

    1. Top of page
    2. Review Series
    3. Review
    4. Pharmacodynamics
    5. Pharmacokinetics/pharmacodynamics
    6. Drug disposition
    7. Drug interactions
    8. Adverse drug reactions
    9. Drug utilization
    10. Short reports
    11. Book review
    12. Conference Report
    13. Announcement
    1. You have free access to this content
      Incidence of adverse drug reactions in paediatric in/out-patients: a systematic review and meta-analysis of prospective studies (pages 77–83)

      Piero Impicciatore, Imti Choonara, Amanda Clarkson, Davide Provasi, Chiara Pandolfini and Maurizio Bonati

      Article first published online: 20 DEC 2001 | DOI: 10.1046/j.0306-5251.2001.01407.x

  8. Drug utilization

    1. Top of page
    2. Review Series
    3. Review
    4. Pharmacodynamics
    5. Pharmacokinetics/pharmacodynamics
    6. Drug disposition
    7. Drug interactions
    8. Adverse drug reactions
    9. Drug utilization
    10. Short reports
    11. Book review
    12. Conference Report
    13. Announcement
    1. You have free access to this content
      Nature, frequency and determinants of prescription modifications in Dutch community pharmacies (pages 85–91)

      Henk Buurma, Peter A. G. M. De Smet, Olga P. Van Den Hoff and Antoine C. G. Egberts

      Article first published online: 20 DEC 2001 | DOI: 10.1046/j.0306-5251.2001.01406.x

  9. Short reports

    1. Top of page
    2. Review Series
    3. Review
    4. Pharmacodynamics
    5. Pharmacokinetics/pharmacodynamics
    6. Drug disposition
    7. Drug interactions
    8. Adverse drug reactions
    9. Drug utilization
    10. Short reports
    11. Book review
    12. Conference Report
    13. Announcement
    1. You have free access to this content
      Dose–response for adrenal suppression with hydrofluoroalkane formulations of fluticasone propionate and beclomethasone dipropionate (pages 93–95)

      Stephen J. Fowler, Linda C. Orr, Andrew M. Wilson, Erika J. Sims and Brian J. Lipworth

      Article first published online: 20 DEC 2001 | DOI: 10.1046/j.0306-5251.2001.bjcp.1399.x

    2. You have free access to this content
      Effect of the CYP2C19 oxidation polymorphism on fluoxetine metabolism in Chinese healthy subjects (pages 96–99)

      Zhao-Qian Liu, Ze-Neng Cheng, Song-Lin Huang, Xiao-Ping Chen, Dong-Sheng Ou-Yang, Chang-Hong Jiang and Hong-Hao Zhou

      Article first published online: 20 DEC 2001 | DOI: 10.1046/j.0306-5251.2001.01402.x

    3. You have free access to this content
      Influence of the CYP2D6*10 allele on the metabolism of mexiletine by human liver microsomes (pages 100–103)

      C. Senda, Y. Yamaura, K. Kobayashi, H. Fujii, H. Minami, Y. Sasaki, T. Igarashi and K. Chiba

      Article first published online: 20 DEC 2001 | DOI: 10.1046/j.0306-5251.2001.01411.x

  10. Book review

    1. Top of page
    2. Review Series
    3. Review
    4. Pharmacodynamics
    5. Pharmacokinetics/pharmacodynamics
    6. Drug disposition
    7. Drug interactions
    8. Adverse drug reactions
    9. Drug utilization
    10. Short reports
    11. Book review
    12. Conference Report
    13. Announcement
    1. You have free access to this content
      Dictionary of pharmacoepidemiology (page 105)

      T. Walley

      Article first published online: 20 DEC 2001 | DOI: 10.1046/j.0306-5251.2001.01419.x

  11. Conference Report

    1. Top of page
    2. Review Series
    3. Review
    4. Pharmacodynamics
    5. Pharmacokinetics/pharmacodynamics
    6. Drug disposition
    7. Drug interactions
    8. Adverse drug reactions
    9. Drug utilization
    10. Short reports
    11. Book review
    12. Conference Report
    13. Announcement
    1. You have free access to this content
  12. Announcement

    1. Top of page
    2. Review Series
    3. Review
    4. Pharmacodynamics
    5. Pharmacokinetics/pharmacodynamics
    6. Drug disposition
    7. Drug interactions
    8. Adverse drug reactions
    9. Drug utilization
    10. Short reports
    11. Book review
    12. Conference Report
    13. Announcement
    1. You have free access to this content
      COST B15: modelling in drug development (pages 118–119)

      Leon Aarons, Luc Balant and Alan Boobis

      Article first published online: 20 DEC 2001 | DOI: 10.1046/j.0306-5251.2001.01408.x

SEARCH

SEARCH BY CITATION